Olema Pharmaceuticals inc (OLMA)
9.83
+0.17
(+1.76%)
USD |
NASDAQ |
May 17, 16:00
9.83
0.00 (0.00%)
Pre-Market: 20:00
Olema Pharmaceuticals Total Liabilities (Quarterly): 27.38M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 27.38M |
| December 31, 2023 | 23.05M |
| September 30, 2023 | 17.66M |
| June 30, 2023 | 16.04M |
| March 31, 2023 | 20.79M |
| December 31, 2022 | 18.10M |
| September 30, 2022 | 14.30M |
| June 30, 2022 | 14.32M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.33M |
| December 31, 2021 | 11.38M |
| September 30, 2021 | 8.901M |
| June 30, 2021 | 8.146M |
| March 31, 2021 | 5.277M |
| December 31, 2020 | 4.585M |
| September 30, 2020 | 5.273M |
| December 31, 2019 | 10.73M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.585M
Minimum
Dec 2020
27.38M
Maximum
Mar 2024
13.64M
Average
13.31M
Median
Total Liabilities (Quarterly) Benchmarks
| Geron Corp | 137.21M |
| Verastem Inc | 77.32M |
| Fate Therapeutics Inc | 143.78M |
| Karyopharm Therapeutics Inc | 373.41M |
| Alpine Immune Sciences Inc | 40.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 263.69M |
| Shareholders Equity (Quarterly) | 236.32M |